Tradestie Institutional Equity Comparison Engine
DMIIU vs DNMXU โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DMIIU Overall Edge
DMIIU Captures Institutional Edge (1โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Drugs Made In America Acquisition II Corp. Unit (DMIIU) driven by superior Momentum & Technical. Fundamentally, DMIIU trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DNMXU at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DMIIU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DNMXU sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
DMIIU N/M vs DNMXU N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
DMIIU
1Y +2.7% vs +0.7% ยท 52W Pos 38% vs 15%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DMIIU
NASDAQ
Drugs Made In America Acquisition II Corp. Unit
Institutional Equity
$10.26
+0.29% 1D
Market Cap
N/A
1M Return
+0.98%
1Y Return
+2.7%
Forward P/E
N/M
Unified AI Score
65.1 / 100
BUY
Tech 75.0
Fund 60.0
Flow 50.0
Mom 50.0
DNMXU
US Equity
DNMXU
Institutional Equity
$10.19
+0.2% 1D
Market Cap
N/A
1M Return
+0.3%
1Y Return
+0.69%
Forward P/E
N/M
Unified AI Score
55.2 / 100
HOLD
Tech 54.0
Fund 51.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DMIIU +2.7%
DNMXU +0.69%
Spread: +1.74 pp (DMIIU Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
DMIIU TTM Op. Margin: N/A
DNMXU TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DMIIU vs DNMXU. Trailing 12-month operating profitability (DMIIU N/A vs DNMXU N/A) and valuation multiples (DMIIU N/M vs DNMXU N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DMIIU | DNMXU | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 38% ($10โ$11) | 15% ($10โ$11) | Stronger Trend | DMIIU |
| Beta / 30D Volatility Risk Regime | -0.01ฮฒ ยท 4% Vol | -0.00ฮฒ ยท 3% Vol | Lower Realized Risk | DNMXU |
| Unified Institutional Score Composite Signal | 65.1 / 100 (BUY) | 55.2 / 100 (HOLD) | Higher Composite | DMIIU |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DMIIU vs DNMXU Buy Guide
DMIIU
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DNMXU
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DMIIU nor DNMXU registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.